Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment

Sliz, E.; Kettunen, J.; Holmes, M.V.; Williams, C.O.; Boachie, C.; Wang, Q.; ... ; Wurtz, P. (2018)

Article / Letter to editor

• lipoproteins
• Mendelian randomization analysis
• metabolomics
• statins

• All authors: Sliz, E.; Kettunen, J.; Holmes, M.V.; Williams, C.O.; Boachie, C.; Wang, Q.; Mannikko, M.; Sebert, S.; Walters, R.; Lin, K.; Millwood, I.Y.; Clarke, R.; Li, L.; Rankin, N.; Welsh, P.; Delles, C.; Jukema, J.W.; Trompet, S.; Ford, I.; Perola, M.; Salomaa, V.; Jarvelin, M.R.; Chen, Z.; Lawlor, D.A.; Ala-Korpela, M.; Danesh, J.; Davey Smith, G.; Sattar, N.; Butterworth, A.; Wurtz, P.
• Date: 2018-11-27
• Journal: Circulation
• Volume: 138
• Issue: 22
• Pages: 2499 - 2512
• DOI: doi:10.1161/CIRCULATIONAHA.118.034942
• Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254781/?report=classic